PL370168A1 - Rozpadająca się w jamie ustnej (orodyspergowalna)kompozycja farmaceutyczna pirybedilu - Google Patents

Rozpadająca się w jamie ustnej (orodyspergowalna)kompozycja farmaceutyczna pirybedilu

Info

Publication number
PL370168A1
PL370168A1 PL03370168A PL37016803A PL370168A1 PL 370168 A1 PL370168 A1 PL 370168A1 PL 03370168 A PL03370168 A PL 03370168A PL 37016803 A PL37016803 A PL 37016803A PL 370168 A1 PL370168 A1 PL 370168A1
Authority
PL
Poland
Prior art keywords
piribedil
composition
orally dispersible
dispersible pharmaceutical
pharmaceutical
Prior art date
Application number
PL03370168A
Other languages
English (en)
Other versions
PL204939B1 (pl
Inventor
Patrick Wuthrich
Herve Rolland
Marc Julien
Original Assignee
Les Laboratoires Servier
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Les Laboratoires Servier filed Critical Les Laboratoires Servier
Publication of PL370168A1 publication Critical patent/PL370168A1/pl
Publication of PL204939B1 publication Critical patent/PL204939B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Psychology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
PL370168A 2002-01-21 2003-01-21 Rozpadająca się w jamie ustnej (orodyspergowalna) kompozycja farmaceutyczna pirybedilu PL204939B1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0200671A FR2834894B1 (fr) 2002-01-21 2002-01-21 Composition pharmaceutique orodispersible de piribedil

Publications (2)

Publication Number Publication Date
PL370168A1 true PL370168A1 (pl) 2005-05-16
PL204939B1 PL204939B1 (pl) 2010-02-26

Family

ID=27589523

Family Applications (1)

Application Number Title Priority Date Filing Date
PL370168A PL204939B1 (pl) 2002-01-21 2003-01-21 Rozpadająca się w jamie ustnej (orodyspergowalna) kompozycja farmaceutyczna pirybedilu

Country Status (26)

Country Link
US (1) US20050085485A1 (pl)
EP (1) EP1467737B1 (pl)
JP (1) JP4500051B2 (pl)
KR (1) KR100588223B1 (pl)
CN (1) CN100352440C (pl)
AR (1) AR038194A1 (pl)
AT (1) ATE327758T1 (pl)
AU (1) AU2003214326B2 (pl)
BR (1) BR0306869A (pl)
CA (1) CA2473152C (pl)
CY (1) CY1105414T1 (pl)
DE (1) DE60305642T2 (pl)
DK (1) DK1467737T3 (pl)
EA (1) EA007286B1 (pl)
ES (1) ES2263959T3 (pl)
FR (1) FR2834894B1 (pl)
GE (1) GEP20063819B (pl)
MA (1) MA27098A1 (pl)
MX (1) MXPA04007035A (pl)
NO (1) NO20043474L (pl)
NZ (1) NZ533820A (pl)
PL (1) PL204939B1 (pl)
PT (1) PT1467737E (pl)
UA (1) UA78277C2 (pl)
WO (1) WO2003061661A1 (pl)
ZA (1) ZA200405008B (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9597278B2 (en) 2008-11-13 2017-03-21 David A. Hamlin Compositions and methods for alleviating hyposalivation and for providing oral comfort
US9884082B2 (en) 2008-11-13 2018-02-06 David A. Hamlin Compositions and methods for alleviating hyposalivation and for providing oral comfort

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE575343A (pl) * 1955-09-09
FR2355502A1 (fr) * 1976-06-23 1978-01-20 Roussel Uclaf Application a titre de medicaments d'un derive de la piperazine et de ses sels
AT376147B (de) * 1980-12-15 1984-10-10 Gergely Gerhard Verfahren und vorrichtung zum granulieren eines pulvergemisches
DE3505433A1 (de) * 1985-02-16 1986-08-21 Basf Ag, 6700 Ludwigshafen Direkttablettierhilfsmittel
DE3506276C1 (de) * 1985-02-22 1986-04-24 Meggle Milchindustrie Gmbh & Co Kg, 8094 Reitmehring Direkttablettiermittel
JP3253127B2 (ja) * 1991-06-07 2002-02-04 帝國製薬株式会社 生理活性ポリペプチド含有製剤
FR2710265B1 (fr) * 1993-09-22 1995-10-20 Adir Composition pharmaceutique bioadhésive pour la libération contrôlée de principes actifs.
NZ278678A (en) * 1994-01-31 1998-03-25 Yamanouchi Pharma Co Ltd Compressed moulded tablet with quick disintegration/dissolution in the mouth, mixture of low and high moldable saccharides as carriers
GB9517062D0 (en) * 1995-08-18 1995-10-25 Scherer Ltd R P Pharmaceutical compositions
GB9700878D0 (en) * 1997-01-17 1997-03-05 Scherer Ltd R P Dosage forms and method for ameliorating male erectile dysfunction
US6024981A (en) * 1997-04-16 2000-02-15 Cima Labs Inc. Rapidly dissolving robust dosage form
JP2001526662A (ja) * 1997-05-09 2001-12-18 フェロンパテント リミテッド 舌下投与式タブレットの製造のための水溶液におけるインターフェロンの安定化
JP2983973B1 (ja) * 1998-10-13 1999-11-29 大正薬品工業株式会社 口腔内速崩壊性固形製剤
JP2000273039A (ja) * 1999-01-20 2000-10-03 Taisho Pharmaceut Co Ltd 口腔内崩壊性組成物
JP2001058944A (ja) * 1999-06-18 2001-03-06 Takeda Chem Ind Ltd 速崩壊性固形製剤
AU2001273496A1 (en) * 2000-07-24 2002-02-05 Boehringer Ingelheim Pharmaceuticals Inc. Apparatus and method for predicting the suitability of a substance for dry granulation by roller compaction using small sample sizes
EP1175899B1 (fr) * 2000-07-27 2007-08-29 Roquette FrÀ¨res Granules à base d'amidon et de lactose
UA80393C2 (uk) * 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
US7118765B2 (en) * 2001-12-17 2006-10-10 Spi Pharma, Inc. Co-processed carbohydrate system as a quick-dissolve matrix for solid dosage forms
FR2834889B1 (fr) * 2002-01-18 2004-04-02 Roquette Freres Forme pharmaceutique solide orodispersible

Also Published As

Publication number Publication date
EP1467737A1 (fr) 2004-10-20
DK1467737T3 (da) 2006-09-18
MXPA04007035A (es) 2004-10-11
GEP20063819B (en) 2006-05-10
ZA200405008B (en) 2005-08-31
FR2834894B1 (fr) 2004-02-27
NZ533820A (en) 2005-08-26
AU2003214326B2 (en) 2007-08-02
PL204939B1 (pl) 2010-02-26
WO2003061661A1 (fr) 2003-07-31
FR2834894A1 (fr) 2003-07-25
PT1467737E (pt) 2006-08-31
MA27098A1 (fr) 2004-12-20
ATE327758T1 (de) 2006-06-15
CA2473152C (fr) 2010-08-31
EA007286B1 (ru) 2006-08-25
CY1105414T1 (el) 2010-04-28
BR0306869A (pt) 2004-11-03
HK1081110A1 (zh) 2006-05-12
CN1688313A (zh) 2005-10-26
DE60305642D1 (de) 2006-07-06
UA78277C2 (en) 2007-03-15
EA200400885A1 (ru) 2004-12-30
CA2473152A1 (fr) 2003-07-31
KR100588223B1 (ko) 2006-06-12
KR20040075098A (ko) 2004-08-26
AR038194A1 (es) 2005-01-05
JP2005529068A (ja) 2005-09-29
JP4500051B2 (ja) 2010-07-14
DE60305642T2 (de) 2007-05-16
ES2263959T3 (es) 2006-12-16
EP1467737B1 (fr) 2006-05-31
US20050085485A1 (en) 2005-04-21
CN100352440C (zh) 2007-12-05
NO20043474L (no) 2004-08-20

Similar Documents

Publication Publication Date Title
PL377518A1 (pl) Dyspergowalne kompozycje farmaceutyczne
GB2389530B (en) Pharmaceutical compositions
EG25453A (en) Deferacirox dispersible tablets
IL164519A0 (en) Pharmaceutical formulations
AU2003291103A8 (en) Pharmaceutical composition
GB2391473B (en) Pharmaceutical compositions
AU2003250372A8 (en) Pharmaceutical composition
ZA200501084B (en) Dispersible tablets for oral administration
HUP0303948A2 (hu) Szájban diszpergálódó szilárd gyógyszerforma
GB2392093B (en) Pharmaceutical formulations
HU0302441D0 (en) Pharmaceutical compositions having antibiothic effect
IL182865A0 (en) Orally dispersible pharmaceutical composition and process for the preaparation thereof
GB0408964D0 (en) Orally administrable pharmaceutical formulation
GB0213481D0 (en) Pharmaceutical compositions
PL370168A1 (pl) Rozpadająca się w jamie ustnej (orodyspergowalna)kompozycja farmaceutyczna pirybedilu
AU2003214326A1 (en) Orally dispersible pharmaceutical piribedil composition
SI1467737T1 (sl) Farmacevtski sestavek piribedila za dispergiranjev ustih
SI1653963T1 (sl) Farmacevtski sestavek piribedila za nazalno aplikacijo
PL370907A1 (pl) Kompozycje farmaceutyczne
IL165843A0 (en) Popping oral administration form
AU2003238900A8 (en) Pharmaceutical formulation
GB0218994D0 (en) Oral pharmaceutical compositions
GB0221068D0 (en) Pharmaceutical compositions
GB0210663D0 (en) Pharmaceutical compositions
GB0209379D0 (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
LAPS Decisions on the lapse of the protection rights

Effective date: 20140121